Skip to main content
TipRanks
Go Ultimate75% OFF

Recordati Industria Chimica e Farmaceutica SPA (RCDTF) Stock Forecast & Price Target

20 Followers
See the Price Targets and Ratings of:

RCDTF Analyst Ratings

Currently, no data available

RCDTF Stock 12 Month Forecast

There Are No Analyst Ratings for RCDTF In The Last 3 Months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for RCDTF
Price TargetArticle
Barclays$55.31hold-4.92%DownsideReiterated07/30/26
Kepler Capital $63.61buy9.34%UpsideReiterated04/21/26
Exane BNP Paribas Analyst forecast on RCDTFUnknown AnalystNot RankedExane BNP Paribas$61.95buy6.49%UpsideInitiated03/03/26
J.P. Morgan$74.12→$77.44buy33.12%UpsideReiterated12/08/25
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Recordati Industria Chimica e Farmaceutica SPA

3 Months
James Gordon
James GordonJ.P. Morgan
Success Rate3/6 ratings generated profit
50%
Average Return
+1.25%

Copying James Gordon's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +1.25% per trade.

1 Year
James Gordon
James GordonJ.P. Morgan
Success Rate3/6 ratings generated profit
50%
Average Return
+4.83%

Copying James Gordon's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +4.83% per trade.

2 Years
James Gordon
James GordonJ.P. Morgan
Success Rate4/6 ratings generated profit
67%
Average Return
+10.42%

Copying James Gordon's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +10.42% per trade.

RCDTF Analyst Recommendation Trends

02468Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for RCDTF
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy00000
Hold11100
Sell00000
Strong Sell00000
total11100

In the current month, RCDTF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. RCDTF average Analyst price target in the past 3 months is ―.

RCDTF Financial Forecast

$-1$-0.25$0.5$1.25$2Q1 2026Q3 2026Q4 2026
Consensus$0.74

RCDTF Earnings Forecast

Next quarter’s earnings estimate for RCDTF is $0.74 with a range of ― to ―. The previous quarter’s EPS was $0.74. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

$739.6M$753.9M$768.2M$782.5M$796.8MQ1 2026Q3 2026Q4 2026
Consensus$774M

RCDTF Sales Forecast

Next quarter’s sales forecast for RCDTF is $773.91M with a range of ― to ―. The previous quarter’s sales results were $773.91M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

RCDTF Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Recordati Industria Chimica e Farmaceutica SPA?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of RCDTF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.